Inhibition of high glucose-induced cardiac fibroblast activation: an effective treatment for diabetic cardiomyopathy using Chinese herbal medicine
Diabetic cardiomyopathy (DCM) is one of the common diabetic microangiopathy in clinical practice. In the early stage of the disease, there are no obvious clinical symptoms. In the middle and late stages, MF, arrhythmia, and even heart failure may occur, affecting the life and health of patients. MF,...
Saved in:
Main Authors: | Bin Wan, Jing Hu, Yue Luo, Yutong Han, Yaowen Zhang, Qinchuan Huang, Yulin Leng, Chunguang Xie |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1523014/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Utilization of Cardiac Magnetic Resonance Imaging for Assessing Myocardial Fibrosis in Prognosis Evaluation and Risk Stratification of Patients with Dilated Cardiomyopathy
by: Xin-Yi Feng, et al.
Published: (2025-01-01) -
Plac8 regulates the fibrogenic ability of cardiac fibroblasts in mice with myocardial infarction
by: Ting Fu, et al.
Published: (2024-12-01) -
Advantages of using T1-mapping in cardiac magnetic resonance imaging in patients with acromegaly
by: Alina A. Almaskhanova, et al.
Published: (2024-12-01) -
Contribution of hypoxia-inducible factor 1alpha to pathogenesis of sarcomeric hypertrophic cardiomyopathy
by: Sarala Raj Murthi, et al.
Published: (2025-01-01) -
Baricitinib represses the myocardial fibrosis via blocking JAK/STAT and TGF-β1 pathways in vivo and in vitro
by: Renlei Feng, et al.
Published: (2025-01-01)